Cell-penetrating DNA-binding protein as a safe and efficient naked DNA delivery carrier in vitro and in vivo

Biochemical and Biophysical Research Communications

Volumn 392, Issue 1, 2010, Pages 9-15

  Kim, Eun Sung ^a   Yang, Seung Woo ^a   Hong, Dong Ki ^a   Kim, Woo Taek ^a   Kim, Ho Guen ^b   Lee, Sang Kyou ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

DNA delivery; DNA binding domain; Intranasal delivery; Protein transduction domain; Upstream activating sequence

Indexed keywords

DNA BINDING PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; NAKED DNA; PLASMID DNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR HPH 1; TRANSCRIPTION FACTOR HPH 1 TRANSCRIPTION FACTOR GAL4 DNA BINDING DOMAIN FUSION PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG PENETRATION; DRUG UPTAKE; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; REPORTER GENE;

CARRIER PROTEINS; DNA; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

MAMMALIA; MUS;

EID: 74849094057     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.135     Document Type: Article

References (30)

1. Jolly D. Viral vector systems for gene therapy. Cancer Gene Ther. 1 (1994) 51-64
2. Ledley F.D. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6 (1995) 1129-1144
3. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
4. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., and Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91 (1994) 664-668
5. Denicourt C., and Dowdy S.F. Protein transduction technology offers novel therapeutic approach for brain ischemia. Trends Pharmacol. Sci. 24 (2003) 216-218
6. Myou S., Leff A.R., Myo S., Boetticher E., Tong J., Meliton A.Y., Liu J., Munoz N.M., and Zhu X. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J. Exp. Med. 198 (2003) 1573-1582
7. Astriab-Fisher A., Sergueev D., Fisher M., Shaw B.R., and Juliano R.L. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19 (2002) 744-754
8. Sakaguchi M., Nukui T., Sonegawa H., Murata H., Futami J., Yamada H., and Huh N.H. Targeted disruption of transcriptional regulatory function of p53 by a novel efficient method for introducing a decoy oligonucleotide into nuclei. Nucleic Acids Res. 33 (2005) e88
9. Normand N., van Leeuwen H., and O'Hare P. Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J. Biol. Chem. 276 (2001) 15042-15050
10. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., and D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. USA 100 (2003) 1972-1977
11. Choi J.M., Ahn M.H., Chae W.J., Jung Y.G., Park J.C., Song H.M., Kim Y.E., Shin J.A., Park C.S., Park J.W., Park T.K., Lee J.H., Seo B.F., Kim K.D., Kim E.S., Lee D.H., and Lee S.K. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat. Med. 12 (2006) 574-579
12. Silver P.A., Keegan L.P., and Ptashne M. Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization. Proc. Natl. Acad. Sci. USA 81 (1984) 5951-5955
13. Fominaya J., and Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J. Biol. Chem. 271 (1996) 10560-10568
14. Paul R.W., Weisser K.E., Loomis A., Sloane D.L., LaFoe D., Atkinson E.M., and Overell R.W. Gene transfer using a novel fusion protein, GAL4/invasin. Hum. Gene Ther. 8 (1997) 1253-1262
15. Fominaya J., Uherek C., and Wels W. A chimeric fusion protein containing transforming growth factor-alpha mediates gene transfer via binding to the EGF receptor. Gene Ther. 5 (1998) 521-530
16. Numata K., Subramanian B., Currie H.A., and Kaplan D.L. Bioengineered silk protein-based gene delivery systems. Biomaterials 30 (2009) 5775-5784
17. Park Y.J., Liang J.F., Ko K.S., Kim S.W., and Yang V.C. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J. Gene. Med. 5 (2003) 700-711
18. Arcasoy S.M., Latoche J.D., Gondor M., Pitt B.R., and Pilewski J.M. Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 4 (1997) 32-38
19. Kim K.D., Choi J.M., Chae W.J., and Lee S.K. Synergistic inhibition of T-cell activation by a cell-permeable ZAP-70 mutant and ctCTLA-4. Biochem. Biophys. Res. Commun. 381 (2009) 355-360
20. Youn J.I., Park S.H., Jin H.T., Lee C.G., Seo S.H., Song M.Y., Lee C.W., and Sung Y.C. Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD. Cancer Gene Ther. 15 (2008) 703-712
21. Bene A., Kurten R.C., and Chambers T.C. Subcellular localization as a limiting factor for utilization of decoy oligonucleotides. Nucleic Acids Res. 32 (2004) e142
22. Griesenbach U., Cassady R.L., Cain R.J., duBois R.M., Geddes D.M., and Alton E.W. Cytoplasmic deposition of NFkappaB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation. Gene Ther. 9 (2002) 1109-1115
23. Sugita T., Yoshikawa T., Mukai Y., Yamanada N., Imai S., Nagano K., Yoshida Y., Shibata H., Yoshioka Y., Nakagawa S., Kamada H., Tsunoda S.I., and Tsutsumi Y. Comparative study on transduction and toxicity of protein transduction domains. Br. J. Pharmacol. 153 (2008) 1143-1152
24. Wadia J.S., Stan R.V., and Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004) 310-315
25. Gump J.M., and Dowdy S.F. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol. Med. 13 (2007) 443-448
26. Ignatovich I.A., Dizhe E.B., Pavlotskaya A.V., Akifiev B.N., Burov S.V., Orlov S.V., and Perevozchikov A.P. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J. Biol. Chem. 278 (2003) 42625-42636
27. Chung S.M., Vaidya M., and Tzfira T. Agrobacterium is not alone: gene transfer to plants by viruses and other bacteria. Trends Plant. Sci. 11 (2006) 1-4
28. Kumagai-Sano F., Hayashi T., Sano T., and Hasezawa S. Cell cycle synchronization of tobacco BY-2 cells. Nat. Protoc. 1 (2006) 2621-2627
29. Illum L. Nasal drug delivery-possibilities, problems and solutions. J. Control. Release 87 (2003) 187-198
30. Nguyen J., Xie X., Neu M., Dumitrascu R., Reul R., Sitterberg J., Bakowsky U., Schermuly R., Fink L., Schmehl T., Gessler T., Seeger W., and Kissel T. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs. J. Gene. Med. 10 (2008) 1236-1246